A Florida jury ruled for Merck in yet another Vioxx case, bringing the drug maker's record to 11-5 in trials related to the drug. The newest case involved a former professional soccer player, Refik Kozic, who had a heart attack in 2001 at the age of 50. The jury decided that Vioxx didn't cause Kozic's heart attack.
Merck, of course, pulled Vioxx from the market in 2004 because of increased risk of heart attack and stroke. Some 45,000 product liability cases are pending.
- check out Merck's release [1]
Related Articles:
NY double-teams Merck in Vioxx lawsuit. Report [2]
Merck takes tough stance on Vioxx. Report [3]
Vioxx defense dealt a blow by new study results. Report [4]
Up to 100,000 Vioxx claims expected. Report [5]
Merck faces long road in Vioxx battle. Report [6]
Links:
[1] http://www.fiercebiotech.com/press-releases/press-release-merck-wins-product-liability-case-florida-circuit-court
[2] http://www.fiercepharma.com/story/ny-double-teams-merck-in-vioxx-lawsuit/2007-09-18?utm_medium=nl&utm_source=link
[3] http://www.fiercepharma.com/story/merck-takes-tough-stance-vioxx/2007-08-21
[4] http://www.fiercebiotech.com/story/vioxx-defense-dealt-a-blow-by-new-study-results/2007-07-03
[5] http://www.fiercebiotech.com/story/spotlight-up-to-100-000-vioxx-claims-expected/2005-05-24
[6] http://www.fiercebiotech.com/story/merck-faces-long-road-in-vioxx-battle/2005-11-04